• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of molcellbPermissionsJournals.ASM.orgJournalMCB ArticleJournal InfoAuthorsReviewers
Mol Cell Biol. Jul 1994; 14(7): 4912–4919.
PMCID: PMC358863

Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence.

Abstract

Capsule formation plays a significant role in the pathogenicity of Cryptococcus neoformans. To study the molecular basis of capsule synthesis, the capsule-deficient phenotype of a mutant strain was complemented by transformation. A plasmid rescued from the resulting Cap+ transformant complemented a cap59 mutation which was mapped previously by classical recombination analysis. Gene deletion by homologous integration resulted in an acapsular phenotype, indicating that we have identified the CAP59 gene. The CAP59 gene was assigned to chromosome I by Southern blot analysis of contour-clamped homogeneous electric field gel electrophoresis-resolved chromosomes of C. neoformans var. neoformans. Sequence comparison of genomic and cDNA clones indicated the presence of six introns. CAP59 encoded a 1.9-kb transcript and a deduced protein of 458 amino acids. Analysis of the nucleotide sequence revealed little similarity to existing sequences in the data bank. When the capsule-deficient phenotype was complemented, the originally avirulent C. neoformans strain became virulent for mice. In addition, the acapsular strain created by gene deletion of CAP59 lost its virulence. This work demonstrates the molecular basis for capsule-related virulence and that the CAP59 gene is required for capsule formation.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.7M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bhattacharjee AK, Bennett JE, Glaudemans CP. Capsular polysaccharides of Cryptococcus neoformans. Rev Infect Dis. 1984 Sep-Oct;6(5):619–624. [PubMed]
  • Bhattacharjee AK, Kwon-Chung KJ, Glaudemans CP. On the structure of the capsular polysaccharide from Cryptococcus neoformans serotype C--II. Mol Immunol. 1979 Jul;16(7):531–532. [PubMed]
  • Bhattacharjee AK, Kwon-Chung KJ, Glaudemans CP. Capsular polysaccharides from a parent strain and from a possible, mutant strain of Cryptococcus neoformans serotype A. Carbohydr Res. 1981 Sep 16;95(2):237–248. [PubMed]
  • Bhattacharjee AK, Kwon-Chung KJ, Glaudemans CP. The major capsular polysaccharide of Cryptococcus neoformans serotype B. Carbohydr Res. 1992 Sep 2;233:271–272. [PubMed]
  • Devereux J, Haeberli P, Smithies O. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 1984 Jan 11;12(1 Pt 1):387–395. [PMC free article] [PubMed]
  • Dromer F, Gueho E, Ronin O, Dupont B. Serotyping of Cryptococcus neoformans by using a monoclonal antibody specific for capsular polysaccharide. J Clin Microbiol. 1993 Feb;31(2):359–363. [PMC free article] [PubMed]
  • Dromer F, Salamero J, Contrepois A, Carbon C, Yeni P. Production, characterization, and antibody specificity of a mouse monoclonal antibody reactive with Cryptococcus neoformans capsular polysaccharide. Infect Immun. 1987 Mar;55(3):742–748. [PMC free article] [PubMed]
  • Edman JC. Isolation of telomerelike sequences from Cryptococcus neoformans and their use in high-efficiency transformation. Mol Cell Biol. 1992 Jun;12(6):2777–2783. [PMC free article] [PubMed]
  • Edman JC, Kwon-Chung KJ. Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation. Mol Cell Biol. 1990 Sep;10(9):4538–4544. [PMC free article] [PubMed]
  • Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. [PubMed]
  • Fromtling RA, Shadomy HJ, Jacobson ES. Decreased virulence in stable, acapsular mutants of cryptococcus neoformans. Mycopathologia. 1982 Jul 23;79(1):23–29. [PubMed]
  • Granger DL, Perfect JR, Durack DT. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J Clin Invest. 1985 Aug;76(2):508–516. [PMC free article] [PubMed]
  • Jacobson ES, Ayers DJ, Harrell AC, Nicholas CC. Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans. J Bacteriol. 1982 Jun;150(3):1292–1296. [PMC free article] [PubMed]
  • Jacobson ES, Payne WR. UDP glucuronate decarboxylase and synthesis of capsular polysaccharide in Cryptococcus neoformans. J Bacteriol. 1982 Nov;152(2):932–934. [PMC free article] [PubMed]
  • Kozel TR. Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide. Infect Immun. 1977 Apr;16(1):99–106. [PMC free article] [PubMed]
  • Kozel TR, Cazin J. Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide. Infect Immun. 1971 Feb;3(2):287–294. [PMC free article] [PubMed]
  • Kwon-Chung KJ. Morphogenesis of Filobasidiella neoformans, the sexual state of Cryptococcus neoformans. Mycologia. 1976 Jul-Aug;68(4):821–833. [PubMed]
  • Kwon-Chung KJ, Edman JC, Wickes BL. Genetic association of mating types and virulence in Cryptococcus neoformans. Infect Immun. 1992 Feb;60(2):602–605. [PMC free article] [PubMed]
  • Kwon-Chung KJ, Rhodes JC. Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect Immun. 1986 Jan;51(1):218–223. [PMC free article] [PubMed]
  • Kwon-Chung KJ, Varma A, Edman JC, Bennett JE. Selection of ura5 and ura3 mutants from the two varieties of Cryptococcus neoformans on 5-fluoroorotic acid medium. J Med Vet Mycol. 1992;30(1):61–69. [PubMed]
  • Still CN, Jacobson ES. Recombinational mapping of capsule mutations in Cryptococcus neoformans. J Bacteriol. 1983 Oct;156(1):460–462. [PMC free article] [PubMed]
  • Toffaletti DL, Rude TH, Johnston SA, Durack DT, Perfect JR. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J Bacteriol. 1993 Mar;175(5):1405–1411. [PMC free article] [PubMed]
  • Turner SH, Cherniak R, Reiss E, Kwon-Chung KJ. Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype A isolates determined by 13C NMR spectroscopy. Carbohydr Res. 1992 Sep 2;233:205–218. [PubMed]
  • Varma A, Edman JC, Kwon-Chung KJ. Molecular and genetic analysis of URA5 transformants of Cryptococcus neoformans. Infect Immun. 1992 Mar;60(3):1101–1108. [PMC free article] [PubMed]
  • White CW, Cherniak R, Jacobson ES. Side group addition by xylosyltransferase and glucuronyltransferase in biosynthesis of capsular polysaccharide in Cryptococcus neoformans. J Med Vet Mycol. 1990;28(4):289–301. [PubMed]
  • Wickes BL, Moore TD, Kwon-Chung KJ. Comparison of the electrophoretic karyotypes and chromosomal location of ten genes in the two varieties of Cryptococcus neoformans. Microbiology. 1994 Mar;140(Pt 3):543–550. [PubMed]

Articles from Molecular and Cellular Biology are provided here courtesy of American Society for Microbiology (ASM)

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links